Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines

J Thromb Haemost. 2022 Apr;20(4):1015-1018. doi: 10.1111/jth.15665. Epub 2022 Feb 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Factor VIII
  • Hemophilia A* / diagnosis
  • Hemophilia A* / drug therapy
  • Hemophilia A* / genetics
  • Humans
  • RNA, Messenger / genetics

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • Factor VIII

Grants and funding